FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of veterinary medicine and pharmaceuticals, namely to a pharmacological agent exhibiting antioxidant and hepatoprotective properties, including sodium thiosulphate (Na2S2O3 or Na2SO3S) and natural aluminosilicate bentonite, characterised by additionally containing slender Russian thistle (Salsola Collina) grass and selenium (Se) at the following ratio of components, mass.%: sodium thiosulphate (Na2S2O3 or Na2SO3S) 11.0 to 12.0; slender Russian thistle (Salsola Collina) grass 9.0 to 10.0; selenium (Se) 1.1 to 1.2; bentonite up to 100.
EFFECT: agent exhibiting antioxidant and hepatoprotective properties.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REMEDY WITH HEPATOPROTECTIVE AND ANTIOXIDANT EFFECTS | 2023 |
|
RU2814114C1 |
| FODDER ADDITIVE FOR CATTLE, HAVING ADAPTOGENIC AND HEPATOPROTECTIVE ACTION WITH HEAT STRESS | 2020 |
|
RU2741641C1 |
| INJECTION AGENT FOR TREATING AND PREVENTING LIVER DISEASES IN ANIMALS | 2019 |
|
RU2702658C1 |
| FEED ADDITIVES FOR POULTRY WITH HEPATOPROTECTIVE AND ANTITOXIC ACTION | 2017 |
|
RU2663994C1 |
| DRUG POSSESSING HEPATOPROTECTIVE ACTIVITY | 2004 |
|
RU2277925C2 |
| PHARMACOLOGICAL INJECTION FOR THE TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2022 |
|
RU2786655C1 |
| MEDICINAL-PROPHYLAXIS AGENT OF CHOLESTEROL-REGULATING ACTION AND A METHOD OF DISEASE TREATMENT CAUSED CHOLESTEROL METABOLISM DAMAGE IN ORGANISM | 1993 |
|
RU2043111C1 |
| COMPOSITION ELICITING ANTITUMOR, HEPATOPROTECTIVE AND IMMUNOSTIMULATING EFFECT | 2002 |
|
RU2221586C1 |
| AGENT WITH HEPATOPROTECTIVE, CHOLESTEROL AND GLUCOSE CONTENT REGULATING EFFECT | 1999 |
|
RU2152221C1 |
| METHOD OF THERAPY OF HEPATOSIS IN COWS | 2023 |
|
RU2814132C1 |
